ARCHIVES

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 34 No. 07 | February 22, 2008

Download PDF Visit The Full Archive

Related Articles

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

NIH grant success rate drops to under 20 percent after 2011 budget cuts

May 13, 2011

NCI To Offer Planning Grants for New Centers

November 9, 1990

In Brief: ACR to Move From Chicago To Washington D.C. Area; Hanks Astro President, Phillips President Elect

December 16, 1983

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

In Brief: Li, Gart Retire Forom NCI; Clifford Heads Diet Branch; ASTRO Meeting Nov. 4-8 In Washington

October 18, 1991